ALLMedicine™ Autoimmune Hepatitis Center
Research & Reviews 1,496 results
https://doi.org/10.1097/HEP.0000000000000183
Hepatology (Baltimore, Md.); Steinmann S, Lohse AW
Mar 18th, 2023 - Treatment of autoimmune hepatitis: Budesonide does not solve our problems.|2023|Steinmann S,Lohse AW,|
https://doi.org/10.1016/j.autrev.2023.103312
Autoimmunity Reviews; Konen FF, Möhn N et. al.
Mar 17th, 2023 - More than 10 disease-modifying therapies (DMT) are approved by the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) for the treatment of multiple sclerosis (MS) and new therapeutic options are on the horizon. Due to di...
https://doi.org/10.1016/j.jep.2023.116365
Journal of Ethnopharmacology; Zhang T, Rao Q et. al.
Mar 13th, 2023 - Tripterygium wilfordii tablets (TWT) is widely used to treat autoimmune diseases such as rheumatoid arthritis. Celastrol, one main active ingredient in TWT, has been shown to produce a variety of beneficial effects, including anti-inflammatory, an...
https://clinicaltrials.gov/ct2/show/NCT05722210
Mar 10th, 2023 - Study Description: Liver dysfunction is common in patients that have undergone hematopoietic stem cell transplant (HSCT) and is associated with increased mortality. We aim to study the natural history of liver dysfunction in HSCT, what factors con...
https://emedicine.medscape.com/article/149684-overview
Mar 10th, 2023 - Background Percutaneous liver biopsy is a procedure in which a long needle is introduced through the skin, subcutaneous tissues, intercostal muscles, and peritoneum into the liver to obtain a specimen of liver tissue. [1, 2] This procedure is usua...
Guidelines 5 results
https://doi.org/10.1016/j.clinre.2022.101871
Clinics and Research in Hepatology and Gastroenterology; Duclos-Vallée JC, Debray D et. al.
Feb 3rd, 2022 - Best practice guidelines for France regarding the diagnosis and management of autoimmune hepatitis.|2022|Duclos-Vallée JC,Debray D,De Martin E,Beux EL,Louvet A,|
https://doi.org/10.1016/j.clinre.2021.101772
Clinics and Research in Hepatology and Gastroenterology; Lemoinne S, Heurgue A et. al.
Aug 1st, 2021 - Autoimmune hepatitis (AIH) is a liver disease characterised by necrotico-inflammatory lesions of hepatocytes, the presence of specific autoantibodies and response to corticosteroid treatment. AIH must be considered in any patient with acute or chr...
https://doi.org/10.1002/hep.31065
Hepatology (Baltimore, Md.); Mack CL, Adams D et. al.
Dec 22nd, 2019 - Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases.|2019|Mack CL,Adams D,Assis DN,Kerkar N,Manns MP,|diagnosis,drug therapy,
https://doi.org/10.1038/ajg.2016.517
The American Journal of Gastroenterology; Kwo PY, Cohen SM et. al.
Dec 21st, 2016 - Clinicians are required to assess abnormal liver chemistries on a daily basis. The most common liver chemistries ordered are serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase and bilirubin. These tests sh...
https://doi.org/10.1002/hep.23584
Hepatology (Baltimore, Md.); Manns MP, Czaja AJ et. al.
Jun 1st, 2010 - Diagnosis and management of autoimmune hepatitis.|2010|Manns MP,Czaja AJ,Gorham JD,Krawitt EL,Mieli-Vergani G,|blood,diagnosis,drug therapy,immunology,pathology,
Drugs 18 results see all →
Clinicaltrials.gov 88 results
https://clinicaltrials.gov/ct2/show/NCT05722210
Mar 10th, 2023 - Study Description: Liver dysfunction is common in patients that have undergone hematopoietic stem cell transplant (HSCT) and is associated with increased mortality. We aim to study the natural history of liver dysfunction in HSCT, what factors con...
https://clinicaltrials.gov/ct2/show/NCT04861571
Mar 9th, 2023 - Study design: The investigators plan to perform a controlled, non-randomized, open-label, pilot clinical trial to evaluate the effect of an 8-week VLCD intervention on NAFLD. The main variable of this study is the magnitude of liver steatosis and ...
https://clinicaltrials.gov/ct2/show/NCT03175471
Mar 2nd, 2023 - Autoimmune liver diseases (AILD), which include Primary Sclerosing Cholangitis (PSC) and Autoimmune Hepatitis (AIH) are a common etiological factors for chronic liver disease among adolescents. In all these conditions, autoimmune lymphocyte respon...
https://clinicaltrials.gov/ct2/show/NCT05751720
Mar 2nd, 2023 - Background: Over the past few decades Non-Alcoholic Fatty liver disease (NAFLD) related non-alcoholic steatohepatitis (NASH) cirrhosis has overtaken all other causes of liver cirrhosis in the developed world, secondary to the rising epidemic of ob...
https://clinicaltrials.gov/ct2/show/NCT05295537
Mar 1st, 2023 - LB remains the gold standard diagnostic test for most of the focal and parenchymal liver diseases. LB has an important diagnostic role in selected parenchymal liver diseases such as autoimmune hepatitis and infiltrative liver disorders, and in som...
News 156 results
https://www.medpagetoday.com/gastroenterology/generalhepatology/103581
Mar 17th, 2023 - Adding time restriction to a calorie-restricted diet didn't provide any additional benefits for nonalcoholic fatty liver disease (NAFLD), the TREATY-FLD trial found. Looking at 88 participants with obesity and NAFLD, the half that followed a calor...
https://www.onclive.com/view/topaz-1-durvalumab-doublet-chemotherapy-in-advanced-biliary-tract-cancers
Oct 27th, 2022 - Transcript: Milind Javle, MD: I’m going to jump right into 1 of the main topics of discussion, which is the role of immune checkpoint inhibitors. I’m going to give you a brief overview of the TOPAZ-1 study for the group, but I’m going to rely on ...
https://www.onclive.com/view/reducing-adverse-events-through-dose-optimization
Oct 18th, 2022 - Transcript: Tanios S. Bekaii-Saab, MD: We have a number of targeted strategies in oncology in solid tumors and the same in GI [gastrointestinal] malignancies. Some other agents that are in use, such as immune checkpoint inhibitors, can be associa...
https://www.onclive.com/view/incidence-and-risk-factors-for-biliary-tract-cancers
Oct 11th, 2022 - Transcript: Milind Javle, MD: Before we get there, Anjana, you mentioned that you’re seeing more patients in your clinic now, and that’s also my experience. We’re seeing a lot more biliary cancer, and I’m amazed that some fellows come to my clini...
https://www.medscape.com/viewarticle/981523
Oct 4th, 2022 - Guidelines on sclerosing cholangitis in adults and children were initially released in June 2022 and published in September 2022 by the European Association for the Study of the Liver (EASL) in the Journal of Hepatology.[1] They provide practical ...